Building Competency in Diabetes Education THE ESSENTIALS

BASAL-BOLUS INSULIN THERAPY | 12-109

1 diabetes mellitus: A randomized controlled trial. Diabetic Medicine 2000;17:762-70. 66. Becker RHA, Frick AD. Clinical pharmacokinetics and pharmacodynamics of insulin glulisine. Clin Pharmacokinet 2008;47:7-20. 67. Kerr D, Morton J, Whately-Smith C, et al. Laboratory-based non-clinical comparison of occlusion rates using three rapid-acting insulin analogs in continuous subcutaneous insulin infusion catheters using low flow rates. J Diabetes Sci Tech 2008;2:450-5. 68. Weinzimer SA, Ternand C, Howard C, et al. A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes. Diabetes Care 2008;31:210-5. 69. Canadian Diabetes Association. Annual Report: Our Focus on Expertise. 2007. 70. Jehle P, Micheler C, Jehl D, et al. Inadequate suspension of neutral protamine hagendorn (NPH) insulin in pens. Lancet 1999;354:1604-7. 71. FIT Forum for Injection Technique Canada: Recommendations for Best Practice Technique, 4 th ed. 2020 72. Cheng AYY, Zinman B. Insulin for treating type 1 and type 2 diabetes. In Gerstein HC, Haynes RB (Eds). Evidence-based diabetes care. Hamilton, Ontario: B.C. Decker, 2001:323-43. 73. American Diabetes Association. Intensive Diabetes Management, 5th ed. J Wolfsdorf (Ed). Alexandria, Virginia. 2012 74. Leadership Sinai Centre for Diabetes. Guidelines for Insulin Dose Adjustments: Policies, Indications, Competencies. Toronto, ON: Mount Sinai Hospital, 2007. 75. Oiknine R, BernbaumM, Mooradian AD. A critical appraisal of the role of insulin analogues in the management of diabetes mellitus. Drugs. 2005;65:325-40. 76. Goldman-Levine J, Lee K. Insulin detemir — a new basal insulin analog. Ann Pharmacother 2005;39:502-7. 77. Yale J. Advancements in Basal Insulin: Tailoring Treatment to Patient Needs. November 10, 2017 Family Medicine Forum. Available at: https://fmf.cfpc.ca/wp- content/uploads/2017/10/F883_Advancements-in-Basal-Insulin_Tailoring-treatment-to- patient-needs.pdf. Accessed August 31, 2018. 78. Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada: Appendix 6: Types of insulin. Can J Diabetes 2018;42(Suppl 1):S314.